Methacholine provocation test for diagnosis of allergic respiratory diseases

V. Brusasco,E. Crimi

DOI: https://doi.org/10.1034/j.1398-9995.2001.00148.x

2001-12-01

Abstract:Airway hyperresponsiveness is regarded as a characteristic feature of bronchial asthma, but it may also be present in other allergic or nonallergic respiratory disorders. The method most widely used to assess airway responsiveness is the methacholine inhalation challenge (1, 2), which mimics the effect of endogenous acetylcholine on airway smooth-muscle muscarinic receptors of the M3 subtype. The major advantage in using methacholine instead of acetylcholine for bronchial challenge lies in its greater resistance to degradation by cholinesterase, which allows one to obtain cumulative dose-response curves. The molecular mechanism by which methacholine causes airway narrowing is by activating the M3-Gq protein coupled receptors and the connected IP3 pathway, an effect which ultimately results in Ca release from intracellular stores and contraction. The mechanisms by which methacholine causes the airways of some individuals to constrict more than others are complex and still largely unknown. This complexity may in part explain the relatively low specificity of this test for the diagnosis of bronchial asthma. In this review, the practical relevance of the different determinants of airway response to methacholine will be discussed, with particular attention to those that may account for the presence of airway hyperresponsiveness in diseases other than asthma.